The Veteran's claim for compensation under 38 U.S.C. § 1151 for chronic pancreatitis secondary to Depakote prescribed for a nonservice connected psychiatric disorder was denied as the effective date cannot be earlier than December 19, 1997.
The deciding factor: The effective date of an award based on VA medical treatment pursuant to 38 U.S.C. § 1151 is fixed in accordance with the facts found but shall not be earlier than the date of receipt of application therefor.
- Claimed conditions
- Chronic Pancreatitis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 60%
- Decision date
- April 16, 2019
- Citation
- 19129515
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Veteran's CT scan at Valley Medical Center was not authorized by VA, and the appeal is denied as no authorization for the procedure was sought or received.
- Denied
The Board finds that the veteran's chronic pancreatitis and diabetes mellitus are not service-connected, as they are due to alcohol abuse and secondary conditions rather than exposure to herbicides or direct service connection.
- Granted
The Board granted service connection for obstructive sleep apnea, effective from the date of the February 2025 rating decision.
- Remanded (sent back)
The Board remands the claim for a medical examination to determine if the Veteran's current neck strain is related to his in-service activities.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.